Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Maladministration of Menveo One-vial presentation after the expiration date; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (expiry date 31-JUL-2025) for prophylaxis. On 04-AUG-2025, the patient received Menveo. On 04-AUG-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Maladministration of Menveo One-vial presentation after the expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 08-AUG-2025 The doctor reported that on 04th August 2025, a patient received Menveo one dose vial presentation after the expiration date (expiration date: 31st July 2025) which led to expired vaccine use. There was no recording on lot number administered.